Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P4HB | P07237 | 7/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 1.00 |
| ▸ | MAOA | P21397 | 4/20 | 1.00 |
| ▸ | EPHX2 | P34913 | 4/20 | 1.00 |
| ▸ | XDH | P47989 | 4/20 | 1.00 |
| ▸ | SLCO2B1 | O94956 | 4/20 | 1.00 |
| ▸ | AKR1B1 | P15121 | 3/20 | 1.00 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | CA12 | O43570 | 2/20 | 1.00 |
| ▸ | CA2 | P00918 | 2/20 | 1.00 |
| ▸ | CA4 | P22748 | 2/20 | 1.00 |
| ▸ | CA7 | P43166 | 2/20 | 1.00 |
| ▸ | NQO2 | P16083 | 1/20 | 0.85 |
| ▸ | MAPT | P10636 | 5/20 | 0.84 |
| ▸ | POLB | P06746 | 4/20 | 0.84 |
| ▸ | GAA | P10253 | 4/20 | 0.84 |
| ▸ | KDM1A | O60341 | 2/20 | 0.84 |
| ▸ | HMGB1 | P09429 | 2/20 | 0.84 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Quercitrin SCHEMBL17628907 | 1.00 | P4HB (1.00) | P4HBKDM4EL3MBTL1MAOAEPHX2 | |
| Quercitrin SCHEMBL29454400 | 1.00 | P4HB (1.00) | P4HBKDM4EL3MBTL1MAOAEPHX2 | |
| Quercitrin SCHEMBL15337986 | 1.00 | P4HB (1.00) | P4HBKDM4EL3MBTL1MAOAEPHX2 | |
| Quercitrin SCHEMBL1697151 | 1.00 | P4HB (1.00) | P4HBKDM4EL3MBTL1MAOAEPHX2 | |
| Quercitrin SCHEMBL6849807 | 1.00 | P4HB (1.00) | P4HBKDM4EL3MBTL1MAOAEPHX2 | |
| Quercitrin SCHEMBL3206092 | 1.00 | P4HB (1.00) | P4HBKDM4EL3MBTL1MAOAEPHX2 | |
| Quercitrin SCHEMBL5456136 | 1.00 | P4HB (1.00) | P4HBKDM4EL3MBTL1MAOAEPHX2 | |
| Quercitrin SCHEMBL4227921 | 1.00 | P4HB (1.00) | P4HBKDM4EL3MBTL1MAOAEPHX2 | |
| Quercitrin SCHEMBL117644 | 1.00 | P4HB (1.00) | P4HBKDM4EL3MBTL1MAOAEPHX2 | |
| Quercitrin SCHEMBL29381705 | 1.00 | P4HB (1.00) | P4HBKDM4EL3MBTL1MAOAEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2895143-B1 | A COMPOSITION FOR TREATMENT OF DEFICITS IN LEARNING AND MEMORY | BIOTROPICS MALAYSIA BERHAD (MY) | 2021-04-07 | — | — | EP | claimed |
| EP-1362021-B1 | METHOD FOR EXTRACTING, FRACTIONATING AND PURIFYING POLYPHENOL COMPOUNDS ORIGINATING FROM FRESH VEGETABLE CULLS USING A HIGH-ABSORPTION AND -ELUTION RESIN | AGRONOMIQUE INST NAT RECH (FR) | 2009-08-05 | — | — | EP | claimed |
| EP-2390325-A1 | FLAVONOID-3-GLUCURONYLTRANSFERASE AND POLYNUCLEOTIDE ENCODING SAME | Suntory Holdings Limited (JP) | 2011-11-30 | — | — | EP | disclosed |
| US-20110258078-A1 | ANONYMOUS SHOPPING TRANSACTIONS ON A NETWORK THROUGH INFORMATION BROKER SERVICES | APPLE INC. | 2011-10-20 | — | — | US | disclosed |
| US-20090325906-A1 | Methods and compositions for therapeutic treatment | LIMERICK BIOPHARMA, INC. | 2009-12-31 | — | — | US | disclosed |
| WO-2009158007-A2 | METHODS AND COMPOSITIONS FOR THERAPEUTIC TREATMENT | LIMERICK BIOPHARMA, INC. (US) | 2009-12-30 | — | — | WO | disclosed |
| EP-2066331-A2 | METHODS FOR TREATING PAIN WITH REDUCED NUASEA AND VOMITING | Limerick BioPharma, Inc. (US) | 2009-06-10 | — | — | EP | disclosed |
| US-20090088394-A1 | METHODS AND COMPOSITIONS FOR THERAPEUTIC TREATMENT | ROBBINS WENDYE | 2009-04-02 | — | — | US | disclosed |
| US-20090082400-A1 | SOLUBLE PYRONE ANALOGS METHODS AND COMPOSITIONS | LIMERICK BIOPHARMA, INC. | 2009-03-26 | — | — | US | disclosed |
| US-20090076053-A1 | METHODS AND COMPOSITIONS FOR TREATING PAIN | EFFLUX TECHNOLOGY, INC. | 2009-03-19 | — | — | US | disclosed |
| WO-2008070346-A9 | METHODS FOR TREATING PAIN WITH REDUCED NUASEA AND VOMITING | LIMERICK BIOPHARMA INC (US) | 2008-08-14 | — | — | WO | disclosed |
| US-20080161248-A1 | Methods and Compositions for Therapeutic Treatment | LIMERICK BIOPHARMA, INC. | 2008-07-03 | — | — | US | disclosed |
| WO-2008070346-A2 | METHODS FOR TREATING PAIN WITH REDUCED NUASEA AND VOMITING | LIMERICK BIOPHARMA, INC. (US) | 2008-06-12 | — | — | WO | disclosed |
| EP-1817023-A2 | METHODS AND COMPOSITIONS FOR TREATING PAIN | Limerick Neurosciences, Inc. (US) | 2007-08-15 | — | — | EP | disclosed |
| US-20070087977-A1 | METHODS AND COMPOSITIONS FOR TREATING PAIN | LIMERICK BIOPHARMA, INC. | 2007-04-19 | — | — | US | disclosed |
| WO-2006055672-A2 | METHODS AND COMPOSITIONS FOR TREATING PAIN | LIMERICK NEUROSCIENCES, INC. (US) | 2006-05-26 | — | — | WO | disclosed |
| US-20060111307-A1 | Methods and compositions for treating pain | LIMERICK NEUROSCIENCES, INC. | 2006-05-25 | — | — | US | disclosed |
| US-20060111308-A1 | Methods and compositions for therapeutic treatment | LIMERICK NEUROSCIENCES, INC. | 2006-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060111307-A1 | Methods and compositions for treating pain | PGF, FABP7, ALPP | P4HB 1574/4885KDM4E 4712/4885L3MBTL1 3801/4885 |
| US-20090325906-A1 | Methods and compositions for therapeutic treatment | SLC2A1, SLC2A2, SLC2A3 | P4HB 1028/4885KDM4E 4285/4885L3MBTL1 4794/4885 |
| US-20070087977-A1 | METHODS AND COMPOSITIONS FOR TREATING PAIN | PGF, FABP7, ALPP | P4HB 1574/4885KDM4E 4712/4885L3MBTL1 3801/4885 |
| US-20090088394-A1 | METHODS AND COMPOSITIONS FOR THERAPEUTIC TREATMENT | PGF, FABP7, ALPP | P4HB 1945/4885KDM4E 4598/4885L3MBTL1 4140/4885 |
| US-20090082400-A1 | SOLUBLE PYRONE ANALOGS METHODS AND COMPOSITIONS | PGF, ABCG2, PYGB | P4HB 1572/4885KDM4E 3210/4885L3MBTL1 4865/4885 |
| US-20090076053-A1 | METHODS AND COMPOSITIONS FOR TREATING PAIN | PGF, FABP7, ALPP | P4HB 1574/4885KDM4E 4712/4885L3MBTL1 3801/4885 |
| US-20060111308-A1 | Methods and compositions for therapeutic treatment | PGF, FABP7, ALPP | P4HB 1945/4885KDM4E 4598/4885L3MBTL1 4140/4885 |
| US-20080161248-A1 | Methods and Compositions for Therapeutic Treatment | PGF, ALPP, CHP1 | P4HB 1957/4885KDM4E 4212/4885L3MBTL1 4301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.